carbamates has been researched along with Hypomelanosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ezogabine (retigabine) was recently approved as an add-on drug for the treatment of partial seizures in adults with epilepsy." | 1.40 | Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine. ( Bergman, R; Didkovsky, E; Feuerman, H; Garin Shkolnik, T; Hodak, E; Kaplan, I; Pavlovsky, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garin Shkolnik, T | 1 |
| Feuerman, H | 1 |
| Didkovsky, E | 1 |
| Kaplan, I | 1 |
| Bergman, R | 1 |
| Pavlovsky, L | 1 |
| Hodak, E | 1 |
1 other study available for carbamates and Hypomelanosis
| Article | Year |
|---|---|
Blue-gray mucocutaneous discoloration: a new adverse effect of ezogabine.
Topics: Adult; Anticonvulsants; Carbamates; Drug Eruptions; Female; Humans; Hypopigmentation; Mucous Membran | 2014 |